Predictors of Critical Care Needs after IV Thrombolysis for Acute Ischemic Stroke
Intravenous (IV) tissue plasminogen activator (tPA) is the only Food and Drug Administration (FDA)-approved treatment for acute ischemic stroke. Post tPA patients are typically monitored in an intensive care unit (ICU) for at least 24 hours. However, rigorous evidence to support this practice is lac...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2014
|
| 在线阅读: | https://doi.org/10.1371/journal.pone.0088652 https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0088652&type=printable |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|